NCT05326204 1 Versus 2 Hours Post Meal Glucose Monitoring in Gestational Diabetes on Treatment
| NCT ID | NCT05326204 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National University of Malaysia |
| Condition | Gestational Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,954 participants |
| Start Date | 2021-12-30 |
| Primary Completion | 2025-12-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,954 participants in total. It began in 2021-12-30 with a primary completion date of 2025-12-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A study to compare between 1 and 2 hours post meal blood glucose monitoring in patients with Gestational Diabetes Mellitus requiring treatment.
Eligibility Criteria
Inclusion Criteria: * Gestational diabetes diagnosed based on National Institute for Health and Care Excellence guideline * requiring treatment either with metformin alone or combined with insulin Exclusion Criteria: * type 1 and 2 diabetes * bad obstetrics history * underlying medical disorders such as Systemic Lupus Erythematosus * fetal anomaly * delivery elsewhere
Contact & Investigator
Rahana Abd Rahman
PRINCIPAL INVESTIGATOR
National University of Malaysia
Frequently Asked Questions
Who can join the NCT05326204 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Gestational Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05326204 currently recruiting?
Yes, NCT05326204 is actively recruiting participants. Contact the research team at drrahana@ppukm.ukm.edu.my for enrollment information.
Where is the NCT05326204 trial being conducted?
This trial is being conducted at Kuala Lumpur, Malaysia.
Who is sponsoring the NCT05326204 clinical trial?
NCT05326204 is sponsored by National University of Malaysia. The principal investigator is Rahana Abd Rahman at National University of Malaysia. The trial plans to enroll 2,954 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.